Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 14, 2023--
Source: eagletribune.com
Page 6 - Joint Proxy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Joint Proxy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Joint Proxy Today - Breaking & Trending Today
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
MEI Pharma, Inc. today reminded shareholders to vote FOR the Company’s pending transaction with Infinity Pharmaceuticals, Inc. in connection with the upcoming special meeting on July 14,...
Source: marketscreener.com
Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 10, 2023--
Source: cadillacnews.com
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote "FOR" Pending Transaction with Infinity Pharmaceuticals
Affirms Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals Highlights Shareholder Opportunity to Participate in Upside Potential of Diversified Combined Pipeline of Three Clinical-Stage Development Programs
Source: marketscreener.com
MEI Pharma Responds to Anson and Cable Car
MEI Pharma, Inc. (NASDAQ: MEIP) (the “Company”) today issued the following statement in response to the disclosure made today by Anson Advisors Inc. and Cable Car Capital LLC: Anson and Cable Car reiterated their formerly disclosed, unsolic...
Source: marketscreener.com